Prevention of Variceal Rebleeding: Stratifying Risk and Individualizing Care

[1]  M. Poca,et al.  Drugs plus ligation to prevent rebleeding in cirrhosis: an updated systematic review , 2014, Liver international : official journal of the International Association for the Study of the Liver.

[2]  A. Albillos,et al.  Secondary prophylaxis for esophageal variceal bleeding. , 2014, Clinics in liver disease.

[3]  J. Bosch,et al.  Patients whose first episode of bleeding occurs while taking a β-blocker have high long-term risks of rebleeding and death. , 2012, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[4]  M. Thiele,et al.  Meta‐analysis: banding ligation and medical interventions for the prevention of rebleeding from oesophageal varices , 2012, Alimentary pharmacology & therapeutics.

[5]  D. Fan,et al.  Transjugular intrahepatic portosystemic shunt for portal vein thrombosis in cirrhosis , 2011, Gut.

[6]  J. Bosch,et al.  Short- and long-term effects of the transjugular intrahepatic portosystemic shunt on portal vein thrombosis in patients with cirrhosis , 2011, Gut.

[7]  Christian Melot,et al.  Deleterious effects of beta‐blockers on survival in patients with cirrhosis and refractory ascites , 2010, Hepatology.

[8]  P. Tandon,et al.  Systematic review: secondary prevention with band ligation, pharmacotherapy or combination therapy after bleeding from oesophageal varices , 2009, Alimentary pharmacology & therapeutics.

[9]  B. Sharma,et al.  Addition of propranolol and isosorbide mononitrate to endoscopic variceal ligation does not reduce variceal rebleeding incidence. , 2009, Gastroenterology.

[10]  P. Hsu,et al.  A randomized, controlled trial of banding ligation plus drug therapy versus drug therapy alone in the prevention of esophageal variceal rebleeding , 2009, Journal of gastroenterology and hepatology.

[11]  I. Ahmad,et al.  Propranolol, isosorbide mononitrate and endoscopic band ligation - alone or in varying combinations for the prevention of esophageal variceal rebleeding. , 2009, Journal of the College of Physicians and Surgeons--Pakistan : JCPSP.

[12]  J. García‐Pagán,et al.  Nadolol plus isosorbide mononitrate alone or associated with band ligation in the prevention of recurrent bleeding: a multicentre randomised controlled trial , 2009, Gut.

[13]  B. González,et al.  Clinical trial: a randomized controlled study on prevention of variceal rebleeding comparing nadolol + ligation vs. hepatic venous pressure gradient‐guided pharmacological therapy , 2009, Alimentary pharmacology & therapeutics.

[14]  P. Hsu,et al.  Improved survival in patients receiving medical therapy as compared with banding ligation for the prevention of esophageal variceal rebleeding , 2008, Hepatology.

[15]  J. Zamora,et al.  Meta-analysis: Combination Endoscopic and Drug Therapy to Prevent Variceal Rebleeding in Cirrhosis , 2008, Annals of Internal Medicine.

[16]  A. Sanyal,et al.  Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. , 2007, The American journal of gastroenterology.

[17]  F. Wong,et al.  Transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis of individual patient data. , 2007, Gastroenterology.

[18]  Catrin Tudur Smith,et al.  Portosystemic shunts versus endoscopic therapy for variceal rebleeding in patients with cirrhosis. , 2006, The Cochrane database of systematic reviews.

[19]  R. Franchis,et al.  Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. , 2005, Journal of hepatology.

[20]  M. Vergara,et al.  Variceal ligation plus nadolol compared with ligation for prophylaxis of variceal rebleeding: A multicenter trial , 2005, Hepatology.

[21]  H. Rousseau,et al.  Improved clinical outcome using polytetrafluoroethylene-coated stents for TIPS: results of a randomized study. , 2004, Gastroenterology.

[22]  J. García‐Pagán,et al.  TIPS versus drug therapy in preventing variceal rebleeding in advanced cirrhosis: A randomized controlled trial , 2002, Hepatology.

[23]  P. Hsu,et al.  The effects of endoscopic variceal ligation and propranolol on portal hypertensive gastropathy: a prospective, controlled trial. , 2001, Gastrointestinal endoscopy.

[24]  Hui-Chun Huang,et al.  Endoscopic Variceal Ligation Plus Nadolol and Sucralfate Compared With Ligation Alone for the Prevention of Variceal Rebleeding: A Prospective, Randomized Trial , 2000, Hepatology.

[25]  Badawy El-Kholy,et al.  Band ligation alone versus band ligation and propranolol in the management of bleeding oesophageal varices , 2000, American Journal of Gastroenterology.

[26]  A. Burroughs,et al.  Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding: A meta‐analysis , 1999, Hepatology.